Skip to content

Comparison between the Camry and the Jamar Dynamometers in measuring hand grip strength in people with Inclusion Body Myositis

Comparison between the Camry and the Jamar Dynamometers in measuring hand grip strength in people with Inclusion Body Myositis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000086369
Enrollment
13
Registered
2026-01-22
Start date
2025-11-05
Completion date
2026-12-31
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A clinical performance comparison study which will assess the reliability and validity of different methods of handheld dynamometry for hand strength in IBM patients. The Camry dynamometer will be compared with the current gold standard dynamometer for measuring grip strength, the Jamar dynamometer. All participants will have grip strength measured using both dynamometry methods and compared. Order of testing will vary.

Interventions

All participants will undergo testing of grip strength using two measurement methods, Jamar (existing 'gold standard' device) and Camry. Camry dynamometer: A commonly used alternative to the Jamar is the Camry dynamometer. The Camry which is a spring type dynamometer has been validated against the Jamar for use in a number of other populations. On a single testing occasion, participants will be asked to sit upright in a supported chair with their hips and knees at 90 degrees. Their feet should

All participants will undergo testing of grip strength using two measurement methods, Jamar (existing 'gold standard' device) and Camry. Camry dynamometer: A commonly used alternative to the Jamar is the Camry dynamometer. The Camry which is a spring type dynamometer has been validated against the Jamar for use in a number of other populations. On a single testing occasion, participants will be asked to sit upright in a supported chair with their hips and knees at 90 degrees. Their feet should be flat on the ground. The shoulder of the side being tested is to be adducted against the side of the body, their unsupported elbow extended at neutral (0 degrees) and their wrist in a neutral position. Participants will then be instructed to grip the device as strongly as they can for 3 seconds. An average score from 3 attempts is recorded. Participants will be randomised to order of testing (Jamar or Camry first). Participants will be asked to use their dominant hand first. All attempts are supervised to ensure adherence to protocol. After a first attempt, there is a 30 second rest period before the second test, and another 30 second rest before the third attempt. This protocol will then be repeated on their non-dominant hand. An average score from the three attempts will be recorded for each side. Following 15 minutes rest time, the participant will be asked to activate the other device and perform three attempts using their dominant hand (with 30 second rest period between attempts). This protocol will then be repeated on the non-dominant side. As before, an average score will be recorded.

Sponsors

Murdoch University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Aged 18 years and older • Has a confirmed diagnosis of Inclusion Body Myositis by a neuromuscular specialist • Able to attend a single study visit of approximately 30 minutes duration during the study period • Able to read and understand the study information and instructions (provided in English) • Able to provide written informed consent for the study • Able to independently and safely use both hand dynamometers (Camry and Jamar)

Exclusion criteria

• Any condition precluding the participant from performing any part of the study procedures. • Any clinical assessment by the Sponsor-Investigator that the participant is unable or unsafe to take part in the study.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026